<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have described a 25-year-old woman with recurrent <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> associated with very high levels of antibodies against <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003493'>Antinuclear antibodies</z:hpo> and clinical features of a defined <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> were absent </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with plasmapheresis, <z:chebi fb="0" ids="8382">prednisone</z:chebi>, intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and <z:chebi fb="8" ids="10033">warfarin</z:chebi> was accompanied by disappearance from the serum of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and the biologic false-positive test for <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e>; IgG anticardiolipin antibodies persisted, however, and the patient had a second <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical improvement ultimately occurred after the dosage of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> was optimized and the level of IgG anticardiolipin antibody decreased to a level lower than any that has been previously associated with thrombotic complications </plain></SENT>
</text></document>